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Magdalene Michael1,2,3, Rumena Begum1,2, Kenneth Fong2, Celine Pourreyrone4, Andrew P. South4,
John A. McGrath2 and Maddy Parsons1
Bullous pemphigoid antigen 1 (BPAG1-e, also known as BP230) is a member of the plakin family of
hemidesmosome cytoskeletal linker proteins that is encoded by an isoform of the dystonin (DST) gene. Recently,
we reported two unrelated families with homozygous nonsense mutations in this DST isoform that led to
ultrastructural loss of hemidesmosomal inner plaques and clinical features of trauma-induced skin fragility. We
now demonstrate that keratinocytes isolated from these individuals have significant defects in adhesion, as well
as increased cell spreading and migration. These mutant keratinocytes also display reduced levels of b4 integrins
at the cell surface but increased total protein levels of keratin-14 and b1 integrins. These alterations in cell
behavior and protein expression were not seen in control keratinocytes in which BPAG1-e expression had been
silenced by stable expression of short hairpin RNA to target DST. The failure of knockdown approaches to
recapitulate the changes in morphology, adhesion, and migration seen in patient cells therefore suggests such
approaches are not appropriate to study loss of this protein in vivo. The contrasting findings in keratinocytes
harboring naturally occurring mutations, however, demonstrate a previously unappreciated key role for BPAG1-e
in regulating keratinocyte adhesion and migration and suggest a requirement for this protein in controlling
functional switching between integrin types in epithelial cells.
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INTRODUCTION
Epidermolysis bullosa (EB) represents a diverse collection of
autosomal dominant and autosomal recessive conditions with
varying degrees of trauma-induced skin and mucous membrane
fragility and, in some cases, extracutaneous abnormalities (Fine
et al., 2008; Fine and Mellerio, 2009a, b). The disease spectrum
of EB (or EB-like disorders) encompasses inherited disorders of
hemidesmosome attachment complexes, keratin intermediate
filaments, focal adhesions, desmosome cell junctions, keratino-
cyte vesicle transport, and enzymes involved in cornification,
and currently involves pathogenic mutations in at least 18
different genes (Bruckner-Tuderman et al., 2013).
One protein that was recently implicated in the pathogen-
esis of EB, is bullous pemphigoid antigen 1 (BPAG1-e, also
known as BP230), a key component of hemidesmosomes
and a member of the plakin family with cytoskeletal linker
properties (Borradori and Sonnenberg, 1999; Leung et al.,
2001a; Litjens et al., 2006; Sonnenberg and Liem, 2007).
BPAG1-e is encoded by the dystonin (DST) gene, the
alternative splicing of which may give rise to multiple tissue
isoforms with variable expression in the skin, neurons,
muscles, and the central nervous system (Leung et al.,
2001b; Jefferson et al., 2006; Young and Kothary, 2007,
2008). The main isoform expressed in the central nervous
system is BPAG1-a, although a further neural variant, BPAG1-
n, may also exist; whether BPAG1-n is expressed in vivo,
however, is uncertain (Leung et al., 2001b). In muscle, the
main isoform is BPAG1-b. In the skin, there is a predominance
of BPAG1-e, and some BPAG1-a and perhaps BPAG1-n may
also be present (Sonnenberg and Liem, 2007).
We recently reported two unrelated cases with a form of
autosomal recessive EB simplex because of homozygous
nonsense mutations in BPAG1-e (Groves et al., 2010; Liu
et al., 2012). The mutations detected were c.3478C4T and
c.3853A4T (GenBank NM_001723.4), which result in the
amino-acid changes p.Gln1124X and p.Arg1249X,
respectively. Clinically, affected individuals had trauma-
induced blistering (generalized but mainly on the feet), and
skin biopsy revealed a lack of hemidesmosomal inner plaques
on transmission electron microscopy and a complete absence
of immunostaining for the BPAG1-e protein using two
isoform-specific monoclonal antibodies.
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In contrast to the clinicopathologic consequences of homo-
zygous nonsense mutations in BPAG1-e, a recent study
demonstrated that depleting BPAG1-e levels in keratinocytes
resulted in rather subtle defects in cell polarity and no
apparent changes in migration speed or adhesion (Hamill
et al., 2009). Thus, the role of BPAG1-e in controlling various
aspects of keratinocyte behavior is unclear. Here, we show
that cells derived from two individuals with loss-of-function
mutations in DST show significant defects in cell morphology,
adhesion, and migration. Contrary to previous knockdown
(KD) studies, however, these cells show increased migration
that results from a loss of surface b4 integrin and increased
active b1 integrin. Our findings confirm a key role for
BPAG1-e in controlling keratinocyte adhesion and motility
and further suggest this protein has an important role
in coordinating maturation of hemidesmosomes and
suppression of focal adhesion dynamics.
RESULTS
DST mutant keratinocytes display altered adhesion and
migration
As the DST gene is known to give rise to multiple isoforms,
gene expression analysis of known tissue-specific isoforms
were analyzed by quantitative PCR in wild-type (WT) kerati-
nocytes. In comparison with total DST gene expression (total
BPAG1), nearly undetectable levels of the muscle-specific and
neuronal isoforms, BPAG1-b and BPAG1-a, respectively were
detected; however, high expression of BPAG1-e was observed
confirming it as the predominant BPAG1 isoform expressed in
keratinocytes (Supplementary Figure S1a online). Comparison
of WT keratinocytes with those isolated from the first DST
patient (DST1) revealed a reduction in total BPAG1 isoform
expression as well as a significant loss of BPAG1-e isoform
expression in DST1 keratinocytes (Supplementary Figure S1b
and c online) confirming the impact of the homozygous
nonsense mutation on BPAG1-e isoform expression. To con-
firm the loss of BPAG1-e in both individuals with loss-of-
function mutations in DST and assess potential changes in
adhesion protein localization, immunostaining for BPAG1-e,
plectin, and collagen XVII, along with differentiation markers,
keratin 14 (K14) and involucrin, was performed on patient
skin sections (DST1 and DST2) compared with samples taken
from healthy volunteers. A total loss of BPAG1-e immuno-
reactivity was observed in both patients as expected but no
overall changes in hemidesmosome localization or differentia-
tion markers were detected (Supplementary Figure S1d, e and
f online, see also Groves et al., 2010; Liu et al., 2012).
Western blot analysis confirmed a loss of BPAG1-e expression
in keratinocytes isolated from both DST patients (Supple-
mentary Figure S1g and h online). Notably, however, the
antibody used to detect BPAG1-e in these experiments
recognized an epitope within the C-terminal region of the
protein, beyond the mutation site identified in both DST
patients. Owing to the lack of reliable antibodies specifically
recognizing BPAG1-e N-terminal epitopes, we were unable to
determine whether a truncated version of the BPAG1-e protein
remained in DST1 and DST2 patient cells. Further analysis of
these cells was conducted using in vitro organotypic assays in
which keratinocytes are grown on top of collagen/Matrigel
three-dimensional scaffolds containing human fibroblasts and
cultured at an air–liquid interface for 2 weeks to mimic a
tissue-like environment (Nystrom et al., 2005). Analysis of
organotypic cultures post-fixation revealed a flattened
morphology of basal keratinocytes in contact with the under-
lying basement membrane in both DST patients compared
with controls (Supplementary Figure S1i online). However,
there were no gross changes in the localization of differentia-
tion markers observed (Supplementary Figure S1j online), in
agreement with previous findings in the patient skin. These
data demonstrate that loss of BPAG1-e expression in kerati-
nocytes leads to alterations in basal keratinocyte morphology
that may be a consequence of altered stability or adhesion to
basement membrane.
In order to analyze these potential attachment defects in
more detail, we quantified adhesion of WT or DST mutant
keratinocytes to the basement membrane matrix Matrigel.
Both DST mutant keratinocyte cell lines showed a significant
delay in adhesion at 30 and 60 minutes post-plating compared
with control cells (Figure 1a and b). Similarly, analysis of cell
detachment demonstrated a significant increase in DST mutant
cell detachment rates compared with controls, suggesting that
adhesions formed in these cells are less stably connected to
the substratum (Figure 1c). Adhesion strengthening is known
to be required for normal keratinocyte migration (Margadant
et al., 2010). We therefore analyzed random migration
behavior of control and DST mutant cells plated at low
density by time-lapse microscopy. Tracking single cells over
time revealed an unexpected increase in migration speed and
directional migration persistence in both DST mutant lines
(Figure 1d, e and f). This is in contrast to a previous study
showing no change in migration in BPAG1-e KD cells in vitro
(Hamill et al., 2009). In order to compare silencing of BPAG1-
e with DST mutant cells, we generated keratinocytes stably
expressing BPAG1-e short hairpin RNA (shRNA) to deplete
BPAG1-e levels byB95% (Figure 2a), and analyzed adhesion
and migration under identical conditions to those above. In
agreement with Hamill et al. (2009), we also found no
difference in adhesion (Figure 2b and c) or migration speed
in the BPAG1-e-depleted cells but a small decrease in
directional persistence of these cells compared with control
Figure 1. Loss of bullous pemphigoid antigen 1 (BPAG1-e) results in decreased adhesion and increased migration speeds. (a, b) Wild-type (WT) and dystonin
(DST) mutant cells were plated and fixed after 30, 60, and 120 minutes. (a) Immunofluorescence images of adherent cells stained with phalloidin A568. Scale
bar¼ 100mm. (b) Quantification of number of adherent cells at indicated time points. (c) Quantification of cell detachment following trypsin treatment. (d–f)
Analysis of random migration of WT and DST mutant keratinocytes. (d) Migration tracks of keratinocytes were analyzed for (e) speed and (f) persistence. For all
quantification, data represent three independent experiments, error bars¼ SEM; *Po0.05, **Po0.01, and ***Po0.001.
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shRNA-expressing cells (Figure 2d–f). These findings indicate
that BPAG1-e controls adhesion strengthening and slows
keratinocyte migration, potentially through control of adhe-
sion complex stability. Importantly, these effects are only
revealed in the DST mutant condition suggesting that the
homozygous nonsense mutation in the DST keratinocytes may
result in alterations in cellular signaling that are not recapitu-
lated by simple depletion of BPAG1-e expression. Alterna-
tively, as discussed in relation to Figure 1, it is possible that a
truncated version of BPAG1-e remains in the DST1 and DST2
cells that we cannot detect using currently available anti-
bodies and that this also contributes to the different
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Figure 2. Knockdown (KD) of bullous pemphigoid antigen 1 (BPAG1-e) does not recapitulate dystonin (DST) mutant adhesion and migration defects.
(a) Western blot analysis of BPAG1-e protein levels in control and BPAG1-e KD keratinocytes. (b, c) Adhesion of BPAG1-e KD cells following 30, 60, and
120 minutes of plating. (b) Immunofluorescence images of cells stained with phalloidin A568. Scale bar¼ 100mm. (c) Quantification of number of adherent cells.
(d–f) Random migration analysis of control and BPAG1-e KD cells. (d) Migration tracks of keratinocytes were analyzed for (e) speed and (f) persistence. (g) Western
blot analysis of control and BPAG1-e KD keratinocytes with keratin 14 antibodies and (h) assessment of KRT14 mRNA levels by reverse-transcriptase–PCR (RT-
PCR), with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a control. (i) FACS analysis of surface levels of b4, b1 total, and b1 active (A) integrins in
control and BPAG1-e KD cells. For all quantification, data represent three independent experiments; error bars¼ SEM; *Po0.05.
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phenotypes observed in the DST cells compared with BPAG1-
e silencing. Similarly, a low level of persisting BPAG1-e
protein in shRNA silenced cells could suffice to maintain
some functionality and/or impart a different phenotype to that
seen in DST mutant cells.
Increased levels of K14 in DST mutant keratinocytes
Given the defects in cell adhesion and migration in BPAG1-e
mutant keratinocytes, we speculated that loss of BPAG1-e may
lead to disruption in other key cytoskeletal proteins and thus
reduced cell adhesion. Indeed, morphometric analysis of cell
monolayers revealed that both DST mutant cell lines showed
significantly larger cell area in monolayers under normal
growth conditions (Figure 3a and b). Western blotting showed
no change in levels of the cytoskeletal proteins actin or tubulin
(data not shown) but revealed a significant increase in levels of
the intermediate filament protein K14 in cells from both DST
patients in comparison with two control keratinocyte cell lines
(Figure 3c and Supplementary Figure S2a online). A similar
increase was also seen at the KRT14 mRNA level by reverse-
transcriptase–PCR (Figure 3d). Incidentally, protein levels of
keratin 5 (K5), the associated partner of K14 was unaffected
(Figure 3e). Conversely, there was no change in K14 protein or
mRNA levels in BPAG1-e KD cells, again demonstrating that
these cells do not recapitulate the abnormal cellular pheno-
types observed in patient cells (Figure 2g and h). Confocal
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analysis demonstrated highly disorganized bundles of K14
filaments within the cytoplasm of BPAG1-e mutant cells
compared with more elaborated networks in controls
(Figure 3a). Given that alterations in K14 function are also
implicated in EB simplex (Coulombe et al., 1991), we sought
to determine whether the K14 upregulation in BPAG1-e-
deficient cells contributed to the adhesion and migration
defects observed. We stably expressed control shRNA or
sequences targeting KRT14 in DST mutant cells to deplete
K14 levels to those seen in control keratinocytes (Figure 3f).
Analysis of adhesion and migration in these K14 ‘rescued’
cells demonstrated no change compared with control DST
cells suggesting that the defective adhesion and motility
observed is not directly because of upregulated K14 in these
cells (Figure 3g and data not shown).
It was previously reported that one of the patients (DST1)
also harbored a mutation in the NOTCH3 gene (Groves et al.,
2010). We confirmed this mutation was not present in the
second DST mutant patient (Liu et al., 2012). Reverse-
transcriptase–PCR analysis of the NOTCH3 downstream
target HES1 mRNA levels in cells treated with the Notch
inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylgly-
cine t-butyl ester (DAPT) revealed a decreased response in
DST1 cells suggesting a constitutive activation of this pathway
(Supplementary Figure 2b online). However, treatment of the
WT or DST1 cells with DAPT did not impact on the altered cell
adhesion or spread area (data not shown) suggesting that these
observed phenotypes are due to the loss of BPAG1-e function
in both cases as opposed to indirect effects via the Notch
pathway.
BPAG1-e loss-of-function results in increased activation of b1
integrins
The defects in cell adhesion and spreading in the DST mutant
cells prompted us to analyze whether loss of BPAG1-e
function resulted in defects in integrin levels or localization.
Analysis of the hemidesmosomal integrins a6 and b4 in skin in
control or DST samples showed no changes in localization of
these proteins at the dermal–epidermal junction in skin
(Figure 4a). Similarly, total b4 integrin protein levels as
assayed by western blotting were identical between control
and DST mutant cells (Figure 4b). However, analysis of cell
surface receptor levels of integrins by FACS revealed a
significant decrease in surface levels of b4 integrins in the
DST mutant cell lines (Figure 4c), which was also evident
using surface antibody staining of non-permeabilized cells and
confocal analysis (Supplementary Figure S2d online). More-
over, analysis of the focal adhesion-associated b1 integrin in
parallel revealed increases in total protein levels in DST1 and
DST2 cells by western blotting (Figure 4b and Supplementary
Figure S2c online) as well as higher cell surface levels of total
and active versions of this integrin as assayed by FACS
(Figure 4d) and immunofluorescence (Supplementary Figure
S2e online). These changes in integrin levels (either total or
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surface exposed receptor) were not seen in BPAG1-e KD cells
(Figure 2i) further supporting our previous suggestions that
shRNA depletion of this protein is not sufficient to mimic the
DST mutant phenotypes. Reduced cell surface b4 integrin
levels and corresponding increases in b1 integrin surface
levels seen in keratinocytes harboring the DST mutation is
also consistent with the concept of a switch in adhesion types
upon loss of this hemidesmosomal component at the cell
membrane. Our data suggest that de-stabilization of hemi-
desmosomes may result in a phenotypic switch to focal
adhesion use, and that this in turn reduces initial stable
adhesions, promotes cell spreading, and cell migration.
DISCUSSION
Mutations in BPAG1-e inhibits keratinocyte adhesion and
enhances migration through regulation of integrin levels
Our analysis of two different human BPAG1-e-deficient cells
has revealed a previously unidentified role for this protein in
controlling keratinocyte cell adhesion and migration, poten-
tially through modulation of integrin stability at adhesion sites.
Loss of BPAG1-e resulted in no change in total b4 integrin
protein levels, but a significant reduction at the cell surface,
suggesting receptor internalization or defects in recycling as a
result of BPAG1-e loss. Notably, a3b1 and a6b1 integrins,
components of focal adhesions, are expressed in basal
keratinocytes and can bind basement membrane extracellular
matrix proteins to mediate basal cell adhesion (Margadant
et al., 2010). However, mouse knockout studies have reported
that the severe adhesion defect exhibited by loss of b4 integrin
could not be compensated by upregulation of a6b1 (DiPersio
et al., 2000; deHart et al., 2003), highlighting the importance
of the a6b4 hemidesmosomal complex in epidermal adhesion
stabilization despite the presence of alternative extracellular
matrix–binding integrins. Conversely, the significant increase
in activation of surface b1 integrins in the DST mutant cells
would seem highly likely to have a key role in the weakened
basal adhesions and favor a more migratory phenotype.
b1 Integrins have a well-established role in keratinocyte
spreading and migration and the consequent upregulation
of b1 could promote the increased spreading and migration
phenotype observed in the DST mutant cells (Grose et al.,
2002). Therefore, a crucial balance of hemidesmosome
versus focal adhesion integrins appears to impact on keratino-
cyte properties, determining adhesion stabilization in an intact
epithelium, or alternatively, permitting a migratory response
during wound healing and repair.
The enhanced migration in DST mutant keratinocytes may
appear to challenge previous suggestions that BPAG1-e is a
positive regulator of migration in mice (Guo et al., 1995),
although these disparities may be explained by the different
approaches used to analyze cell migration. Guo et al. (1995)
assessed the collective, directional migration of the epidermal
layer in Bpag1 / mice in response to wounding of the skin,
a complex process involving the establishment of polarity in
the direction of migration, maintenance of intercellular
adhesion, and regulation of basement membrane interactions
(Guo et al., 1995; Friedl and Gilmour, 2009). This study in
contrast utilized an in vitro approach to analyze the random
migratory behavior of keratinocytes on basement membrane
proteins in the absence of stimuli, which requires the
coordination of protrusive signals and basement membrane
adhesion (Ridley et al., 2003). Given the change in integrin
balance identified here, analyzing the cell–cell versus cell–
matrix adhesion strengthening in BPAG1-e null cells will be
an important area to pursue in future studies.
DST mutation alters K14 expression in basal keratinocytes
Integrins a6b4 and a3b1 share binding to common extra-
cellular ligands although their cytoplasmic regions interact
with different cytoskeletal structures. a6b4 Connects the
basal keratinocyte adhesions to the keratin cytoskele-
ton whilst a3b1 is linked indirectly to actin filaments.
Adhesion via a6b4 is stabilized through linkages to K5 and
K14 filaments, mediated though an association with plectin
and BPAG1-e (Tsuruta et al., 2011). Here, we report a role
for BPAG1-e in the regulation of keratin filament assembly in
epithelial cells. Ultrastructural analysis of DST mutant skin
revealed detachment of keratin filaments from adhesive
structures leading to poorly formed hemidesmosomal inner
plaques (Groves et al., 2010; Liu et al., 2012). Interestingly,
DST mutant cells exhibited an aberrant upregulation of
KRT14 gene and K14 protein expression suggesting that
loss of linkage between the K14 filaments and the associated
membrane adhesion components results in altered signaling
cues that stimulate keratin expression, possibly as a
compensatory mechanism. Therefore, it could be inferred
that establishment of a continuous linkage between the
adhesion components and the keratin filament network
generates a negative feedback signal to regulate KRT14
gene expression. Interestingly, a recent study revealed that
loss of keratin resulted in increased adhesion rates (Seltmann
et al., 2013); however, our data show that the defective
adhesion rates in DST mutant cells are not rescued in cells
where K14 was reduced to endogenous levels, indicating
that the increased K14 protein levels do not directly
contribute to this phenotype but instead structural
abnormalities may exist in the keratin cytoskeleton in DST
mutant cells.
Homozygous nonsense mutations in DST do not recapitulate the
BPAG1-e KD phenotype
A surprising finding in this study was the observation that the
DST mutant cells do not display the same phenotype as
BPAG1-e KD keratinocytes. Our data further confirm results
reported by Hamill et al. (2009) that keratinocytes stably
transduced with lentiviral-mediated shRNA-targeting
BPAG1-e exhibit no alterations in integrin levels, adhesion
impairment, or changes in migration speeds, albeit with a
small decrease in persistence (Hamill et al., 2009). As in the
case of Hamill et al. (2009), a robust depletion of 490%
BPAG1-e protein was achieved by lentiviral-mediated
transduction in this study. However, the contrasting
phenotypes displayed by BPAG1-e KD keratinocytes
compared with DST mutants, suggests that the remnant
BPAG1-e expressed because of incomplete depletion in the
shRNA KD system could be sufficient to preserve the basic
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keratinocyte properties and function. Although the previous
report on the first DST patient skin demonstrated that the
homozygous nonsense mutation does not lead to nonsense-
mediated decay of the mRNA, it is still uncertain if the
putative truncated protein is indeed expressed in the DST
mutant tissue because of lack of suitable antibodies to detect
the N-terminal region of BPAG1-e (Groves et al., 2010; Liu
et al., 2012). It remains plausible that although gene products
upstream of the nonsense mutation were detected, the
resultant truncated protein could be unstable and subject
to degradation. Furthermore, our observations that gene
expression of all BPAG1 isoforms, determined by ampli-
fication of a region upstream of the BPAG1-e nonsense
mutations, is reduced in the DST mutant keratinocyte
implies that there may also be reduced gene expression of
the N-terminal regions of BPAG1-e, as it is the predominant
isoform in keratinocytes. Alternatively, the putative truncated
BPAG1-e, which lacks the keratin binding C-terminal region
but still harbors binding sites for b4 integrin and collagen
XVII (Koster et al., 2003), could exert a dominant-negative
effect on the hemidesmosomal complex resulting in the
observed alterations in integrin signaling and adhesion
dynamics. However, lack of antibodies to specifically
report on levels of a potential truncated BPAG1-e protein
make it currently impossible to determine which of these
possibilities exists in either DST1 or DST2 cell lines. It should
be noted that relative expression of both the muscle- and
brain-specific isoforms were increased in DST mutant
keratinocytes compared with WT (data not shown),
however, as these isoforms are expressed at very low levels
in WT cells it hard to envisage their contribution to the
phenotype observed in the DST cells through a compensatory
mechanism. Future investigations to specifically test the
effect of expressing this truncated form of BPAG1-e in
BPAG1-e KD keratinocytes may help to provide further
insight into the differences in the phenotypes observed.
In summary, these findings point to a previously un-
appreciated critical role for BPAG1-e in the regulation of
keratinocyte hemidesmosomal adhesion through the control of
integrin signaling and keratin organization. This study also
highlight the importance of analyzing potential roles of
BPAG1-e and related BPAG1 isoforms in other skin blistering
or fragility disorders in future.
MATERIALS AND METHODS
Plasmids and reagents
pLKO.1 lentiviral shRNA libraries for BPAG1-e and KRT14 were
purchased from Open Biosystems (Thermo Scientific, Northumberland,
UK). The shRNA sequences used for BPAG1-e KD was 50-
TAATTCTGAGTAATACAGAGC-30 and 50-AAACCCAGGGCTGCCTT
GGAAAAG-30 and 50-AAACCCAGGGCTGCCTTGGAAAAG-30 were
used for K14KD1 and K14KD2, respectively. Lentiviral packaging
plasmids: pMDG, and pD8.91. Primary antibodies human-anti-BP230,
plectin, collagenXVII, a6 integrin, b4 integrin and K14 were used
previously in (Groves et al., 2010). Other primary antibodies: mouse
anti-BP230 (2B Scientific, Oxford, UK), total b1 integrin (Millipore,
Watford, UK), active b1 integrin (clone 12G10, Millipore), and
involucrin (Serotec, Oxford, UK). Secondary antibodies: horseradish
peroxidase-conjugated secondary antibodies (Dako, Ely, UK), Alexa
488, Alexa 568-conjugated anti-rabbit and anti-mouse (Invitrogen,
Paisley, UK), Cy5-conjugated anti-rabbit and mouse (Zymed,
Invitrogen). Other reagents: 4,6-diamidino-2-phenylindole and Alexa
568-conjugated phalloidin (Invitrogen), DAPT (Calbiochem, Watford,
UK), and puromycin (Sigma, Dorset, UK).
Cell culture and shRNA KDs
All keratinocyte cell lines were cultured in keratinocyte serum-free
medium media (Invitrogen) supplemented with penicillin and strep-
tomycin. DST1 and DST2 cell lines were obtained by isolation of
primary keratinocytes from EB simplex patient biopsies and human
papillomavirus immortalization (Groves et al., 2010; Liu et al., 2012).
The WT1 human keratinocyte cell line, NEB-1, was a gift from Dr
Graham Neill (Morley et al., 1995) and an additional control
keratinocyte cell line (K17; WT2) was generated by isolation of
keratinocytes from a 51-year-old female breast and human
papillomavirus immortalization in an identical manner to both of
the DST mutant patient cell lines. Following written and informed
consent, blood and skin samples were obtained from the patient in
adherence to the Declaration of Helsinki Principles. Ethical approval
for the study was granted by Guy’s and St Thomas’ NHS Foundation
Trust and King’s College London. HEK293T cells for lentivirus
production were cultured in RPMI media supplemented with 10%
fetal calf serum, penicillin, streptomycin, and L-glutamine. BPAG1-e
KD and control cell lines were generated by lentiviral-mediated
transduction of WT keratinocytes with BPAG1-e shRNA and control
constructs. Infected cells were selected using 2mg ml–1 puromycin.
Similarly, the KRT14KD cell line was made by lentiviral infection of
the DST1 cell line with the KRT14 shRNA construct and puromycin
selection.
Flow cytometry
Cultured WT, DST1, and DST2 were scraped off with phosphate-
buffered saline (PBS) and fixed with 4% paraformaldehyde for
20 minutes. Cells were then blocked for 60 minutes with 2% BSA in
PBS and incubated with primary antibody for 90 minutes. Cells were
washed three times in PBS, incubated with secondary antibody for
45 minutes, washed again and resuspended in PBS for FACS analysis.
As a negative control, the primary antibody was omitted in the
experiment. Mean fluorescent values were subtracted against the
negative control and normalized to the WT values.
Immunofluorescence and microscopy
Keratinocytes were grown in keratinocyte grown medium media
(MEM Alpha Eagle’s medium supplemented with insulin, epidermal
growth factor, adenine, hydrocortisone, penicillin, and streptomycin)
on Matrigel (BD Biosciences, Oxford, UK)-coated glass coverslips for
48 hours to form confluent monolayers. Cells were then fixed for
20 minutes with 4% paraformaldehyde, permeabilized for 2 minutes
with 0.1% Tx-100 in PBS, blocked for 60 minutes in 10% fetal calf
serum in PBS, and incubated with primary antibody for 90 minutes.
Cell were washed in PBS and incubated with secondary antibody for
45 minutes and washed again before mounting on glass slides using
FluorSafe reagent. For skin immunofluorescence microscopy, the
tissue was fixed for 30 minutes, permeabilized for 5 minutes, blocked
for 1 hour before overnight incubation with the primary antibody.
Samples were washed in PBS, incubated with the secondary antibody
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for 90 minutes, washed again, and mounted. Confocal microscopy
was performed on the Zeiss LSM510 point scanning microscope (Carl
Zeiss, Oberkochen, Germany). Wide-field microscopy as performed
on the Olympus IX81 (Olympus KeyMed, Southend, UK) (Meta-
morph, Sutter filter wheels, ASI X-Y stage, Photometrics CascadeII
512B camera).
Organotypic cultures
The development of organotypic cultures was performed similar
to the protocol used in Nystrom et al. (2005). Briefly, keratino-
cytes were grown on a matrix of collagen and Matrigel (1:1)
embedded with human dermal fibroblasts. After 48 hours, keratino-
cytes on the gel was raised onto an air–liquid interface and grown
for 11 days, followed by paraformaldehyde fixation and paraffin
embedding.
Cell adhesion and detachment assay
For the adhesion assay, 100,000 cells per well were plated onto
matrigel-coated coverslips placed in 24-well dishes. Adherent cells
were then fixed after 30, 60, 120 minutes by rinsing twice with PBS
and paraformaldehyde fixation for 20 minutes. Cells were stained
with 4,6-diamidino-2-phenylindole and phalloidin-Alexa568 and
5 5 tilescan images were acquired on a wide-field microscope.
Images were quantified using CellProfiler image analysis software
(Broad Institute, Cambridge, MA). For the cell detachment assays, cells
were plated at 50,000 cells per well in 24-well dishes and grown for
48 hours. The number of detached cells was then counted following
5 minutes of trypsin-EDTA incubation and normalized against the
number of detached cells after 15 minutes (total cell count).
Migration assays
Phase contrast time-lapse imaging of cells were performed on a Zeiss
Axio100 microscope equipped with Sensicam CCD camera (PCO
Cooke), motorized stage (Ludl) and excitation/emission filters
(Chroma) and filter wheels (Ludl). Images were acquired using a
10x phase objective. For random migration analysis, cells were plated
for 4 hours at 8,000 cells per well in 12-well dishes. Time-lapse
movies were taken at 5 minutes per frame for 8 hours. The cell movies
were then tracked using the AndorIQ (Andor, Belfast, UK) software
and migration speeds and persistence was analyzed using in-
house Mathematica6 (Wolfram) notebooks written and designed by
Professor Graham Dunn (King’s College London, London, UK).
Reverse-transcriptase–PCR
WT and DST1 keratinocytes were subject to RNA extraction (Qiagen,
Manchester, UK) followed by reverse transcription (Superscript III,
Invitrogen) according to the manufacturer’s instructions. Gene expres-
sion analysis of the BPAG isoforms in WT and DST1 cells were
performed using Taqman gene expression assays (Applied Biosystems,
Life Technologies, Paisley, UK). The primer/probe set used for each
isoform are as follows: total BPAG1 (Hs00156137_m1), BPAG1-e
(Hs01094846_g1), BPAG1-b (Hs01094902_m1), and BPAG-a
(Hs01094853_m1). Semiquantitative reverse-transcriptase–PCR
was performed using primers against HES1 (forward 50-CGGACATT
CTGGAAATGACA-30, reverse 50-TACTTCCCCAGCACACTTGG-30),
NOTCH3 (forward 50-GTGTGTGTCAATGGCTGGAC-30, reverse 50-
GTGACACAGGAGGCCAGTCT-30), KRT14 (forward 50-CCCTACTTC
AAGACCATTGAGGAC-30, reverse 50-GTGACACAGGAGGCCAGT
CT-30) and GAPDH (forward 50-AGAAGGCTGGGGCTCATTTG-30,
reverse 50-AGGGGCCATCCACAGTCTTC-30).
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